Clinical trial

Firategrast (SB683699) Surface Area Study in Multiple Sclerosis Patients

NCT00548769

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-04-21

PhasePHASE1

Study timeline

Study start (actual)2007-04-21Date precision: day

Registry last updated2017-08-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

Formulation ADRUG

Formulation BDRUG

Formulation CDRUG

Formulation DDRUG

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

BerlinGermany1 PragueCzechia1 PoznanPoland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00548769 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.